(Q34458659)

2 August 2017

1 reference

title

Quality-of-life assessment in patients with benign prostatic hyperplasia: effects of various interventions (English)

1 reference

2 August 2017

1 reference

prostatic hypertrophy

1 reference

Batista-Miranda JE

1

1 reference

2 August 2017

Diez MD

series ordinal

2

1 reference

2 August 2017

Bertrán PA

series ordinal

3

1 reference

2 August 2017

Villavicencio H

series ordinal

4

1 reference

2 August 2017

publication date

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

19

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

1079-1090

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200119110-00002

2 August 2017

exact match

0 references

cites work

Measuring quality of life in clinical trials: a taxonomy and review

1 reference

12 December 2020

Relief of BPO or improvement in quality of life?

1 reference

12 December 2020

Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up

1 reference

12 December 2020

Validation of a symptoms questionnaire for benign prostatic hyperplasia

1 reference

12 December 2020

Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study. Primary Care Investigator Study Group.

1 reference

12 December 2020

Improved indication and followup in transurethral resection of the prostate using the computer program CLIM: a prospective study

1 reference

12 December 2020

The measurement of symptoms, quality of life and sexual function

1 reference

12 December 2020

Interstitial laser coagulation for management of benign prostatic hyperplasia: a Japanese experience

1 reference

12 December 2020

Efficacy, tolerability, and effect on health-related quality of life of finasteride versus placebo in men with symptomatic benign prostatic hyperplasia: a community based study. CUSP Investigators. Community based study of Proscar

1 reference

12 December 2020

Transurethral electrovaporization of the prostate--a possible alternative to transurethral resection: a one-year follow-up of a prospective randomized trial.

1 reference

12 December 2020

Benign prostatic hyperplasia: natural evolution versus medical treatment

1 reference

12 December 2020

Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men.

1 reference

12 December 2020

A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia

1 reference

12 December 2020

A new patient weighted symptom score system (DAN-PSS-1). Clinical assessment of indications and outcomes of transurethral prostatectomy for uncomplicated benign prostatic hyperplasia

1 reference

12 December 2020

Cost consequences of surveillance, medical management or surgery for benign prostatic hyperplasia.

1 reference

12 December 2020

Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy.

1 reference

12 December 2020

A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study

1 reference

12 December 2020

Quality of life assessment in patients treated with lower energy thermotherapy (Prostasoft 2.0): results of a randomized transurethral microwave thermotherapy versus sham study.

1 reference

12 December 2020

The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.

1 reference

12 December 2020

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

12 December 2020

Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study.

1 reference

12 December 2020

Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.

1 reference

12 December 2020

LONG-TERM RESULTS OF LOWER ENERGY TRANSURETHRAL MICROWAVE THERMOTHERAPY

1 reference

12 December 2020

Quality of life, voiding symptoms and uroflowmetry in healthy males and benign prostatic hyperplasia (BPH) patients

1 reference

12 December 2020

The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

12 December 2020

Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasia. Finasteride Study Group.

1 reference

12 December 2020

The Natural History of Untreated “Prostatism”

1 reference

12 December 2020

A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study

1 reference

12 December 2020

A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.

1 reference

12 December 2020

Outcome of elective prostatectomy

1 reference

12 December 2020

Medical therapy for benign prostatic hyperplasia: a review of the literature

1 reference

12 December 2020

A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate

1 reference

12 December 2020

[The use of the IPSS questionnaire in surgical patients. International Prostatic Symptom Score]

1 reference

12 December 2020

Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men.

1 reference

12 December 2020

Construction and validation of a short-form benign prostatic hypertrophy health-related quality-of-life questionnaire. BPH Group in General Practice.

1 reference

12 December 2020

Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.

1 reference

12 December 2020

The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate

1 reference

12 December 2020

A possible condition of pre-instability in prostatic obstruction.

1 reference

12 December 2020

Validation of a new quality of life questionnaire for benign prostatic hyperplasia

1 reference

12 December 2020

Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association.

1 reference

12 December 2020

Association of health-related quality of life and benign prostatic enlargement.

1 reference

12 December 2020

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

1 reference

12 December 2020

1 reference

12 December 2020

Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men.

1 reference

12 December 2020

Impact of drug therapy on benign prostatic hyperplasia-specific quality of life

1 reference

12 December 2020

Laser ablation of the prostate in patients with benign prostatic hypertrophy

1 reference

12 December 2020

Quality of life changes following KTP/Nd:YAG laser treatment of the prostate and TURP.

1 reference

12 December 2020

A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia

1 reference

12 December 2020

Holmium laser resection of the prostate is more cost effective than transurethral resection of the prostate: results of a randomized prospective study

1 reference

12 December 2020

[The IPPS questionnaire in patients and controls. Psychometric validation]

1 reference

12 December 2020

A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy

1 reference

12 December 2020

Predictors of general quality of life in patients with benign prostate hyperplasia or prostate cancer.

1 reference

12 December 2020

10.2165/00019053-200119110-00002

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xfumqilusrgh7iha6fy7cv2d4m

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1000572648

0 references

Fatcat ID

release_xfumqilusrgh7iha6fy7cv2d4m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xfumqilusrgh7iha6fy7cv2d4m

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/xfumqilusrgh7iha6fy7cv2d4m

1 reference

30 July 2022